AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

Starting the Discussion: A Call to Enhance Care for People with Stimulant Use Disorder

Nov 8, 2023 by agalloway

The article, “Starting the Discussion: A Call to Enhance Care for People with Stimulant Use Disorder,” has been published in SAj.

In this commentary, the authors state stimulant use disorder (StUD) significantly contributes to substance-related morbidity and mortality in the United States. Overshadowed by the country’s focus on opioid-related overdose deaths, stimulant and stimulant/opioid overdose deaths have increased dramatically over the last decade. Many individuals who use stimulants illicitly or have StUD have multiple, intersecting stigmatized characteristics which exacerbate existing barriers and create new obstacles to attaining addiction treatment. Illicit stimulant use, StUD, and stimulant-related overdose disproportionately impact minoritized racial and gender, and sexuality diverse groups.

In the AUTHORS’ OWN WORDS, they relate the importance of their work:

“As with anything in medicine, we strive for progress, not perfection. Improving the care of people with StUD will require a multilevel response, and society, institutions, and individuals must all be open to change. Societally we must address stigma about people who use drugs, specifically those who use stimulants, and change the narrative in the media and public discourse that leads to fear and discrimination. Institutionally, we must commit to changing existing harmful and long-held practices and protocols that do not adequately meet the needs or serve people most likely to have a StUD. Healthcare providers must also commit to adopting evidence-based methods to care for people with StUD to move beyond creating a non-stigmatizing environment to one that is also engaging and responsive. Individually, all of us must re-examine our personal beliefs and stigmas about people with StUD and actively change our thoughts and behaviors. Words matter, but so do actions. Building a more inclusive and responsive addiction treatment environment for people with a StUD will not be easy, but it is necessary and long overdue.”

Filed Under: SAj Blog, Uncategorized

Copyright © 2025
Site by: web360